Chairman, President & CEO of Idexx Laboratories (IDXX) Jonathan W Ayers sells 15,000 shares of IDXX on 11/27/2012 at an average price of $92.67 a share.

Idexx Laboratories has a market cap of $5.35 billion; its shares were traded at around $90.94 with a P/E ratio of 31 and P/S ratio of 4.4. Idexx Laboratories had an annual average earning growth of 16.7% over the past 10 years. GuruFocus rated Idexx Laboratories the business predictability rank of 5-star.

CEO Recent Trades:

Chairman, President & CEO Jonathan W Ayers sold 15,000 shares of IDXX stock on 11/27/2012 at the average price of 92.67. Jonathan W Ayers owns at least 378,133 shares after this. The price of the stock has decreased by 1.87% since.

Chairman, President & CEO Jonathan W Ayers sold 15,000 shares of IDXX stock on 11/13/2012 at the average price of 89.92. Jonathan W Ayers owns at least 373,133 shares after this. The price of the stock has increased by 1.13% since.

Chairman, President & CEO Jonathan W Ayers sold 13,392 shares of IDXX stock on 11/06/2012 at the average price of 94.06. Jonathan W Ayers owns at least 365,749 shares after this. The price of the stock has decreased by 3.32% since.

Chairman, President & CEO Jonathan W Ayers sold 15,000 shares of IDXX stock on 10/24/2012 at the average price of 96.42. Jonathan W Ayers owns at least 361,749 shares after this. The price of the stock has decreased by 5.68% since.

Chairman, President & CEO Jonathan W Ayers sold 15,000 shares of IDXX stock on 10/15/2012 at the average price of 96.76. Jonathan W Ayers owns at least 356,749 shares after this. The price of the stock has decreased by 6.01% since.

CFO Recent Trades:

Executive VP & CFO Merilee Raines sold 7,726 shares of IDXX stock on 11/14/2012 at the average price of 90.27. Merilee Raines owns at least 159,451 shares after this. The price of the stock has increased by 0.74% since.

Executive VP & CFO Merilee Raines sold 25,000 shares of IDXX stock on 11/06/2012 at the average price of 93.84. Merilee Raines owns at least 159,451 shares after this. The price of the stock has decreased by 3.09% since.

Executive VP & CFO Merilee Raines sold 7,726 shares of IDXX stock on 10/10/2012 at the average price of 96.08. Merilee Raines owns at least 184,451 shares after this. The price of the stock has decreased by 5.35% since.

Executive VP & CFO Merilee Raines sold 7,726 shares of IDXX stock on 09/12/2012 at the average price of 98.29. Merilee Raines owns at least 184,451 shares after this. The price of the stock has decreased by 7.48% since.

Executive VP & CFO Merilee Raines sold 7,726 shares of IDXX stock on 08/08/2012 at the average price of 88.84. Merilee Raines owns at least 184,451 shares after this. The price of the stock has increased by 2.36% since.

Directors and Officers Recent Trades:

Corporate Vice President Ali Naqui sold 3,504 shares of IDXX stock on 11/14/2012 at the average price of 90.05. Ali Naqui owns at least 11,920 shares after this. The price of the stock has increased by 0.99% since.

Executive Vice President Michael J Phd Williams sold 13,743 shares of IDXX stock on 11/12/2012 at the average price of 89.14. Michael J Phd Williams owns at least 9,965 shares after this. The price of the stock has increased by 2.02% since.

Director Brian P Mckeon sold 6,666 shares of IDXX stock on 11/08/2012 at the average price of 90.48. Brian P Mckeon owns at least 12,341 shares after this. The price of the stock has increased by 0.51% since.

Director Rebecca M Henderson sold 1,000 shares of IDXX stock on 11/06/2012 at the average price of 94.51. Rebecca M Henderson owns at least 7,348 shares after this. The price of the stock has decreased by 3.78% since.

Executive Vice President Michael J Phd Williams sold 2,937 shares of IDXX stock on 11/01/2012 at the average price of 96.02. Michael J Phd Williams owns at least 7,465 shares after this. The price of the stock has decreased by 5.29% since.

Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.
Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.